(Q40868758)

24 September 2017

Deciphering the role of interleukin-22 in metabolic alterations (English)

1 reference

24 September 2017

Robert Sabat

1

1 reference

24 September 2017

Kerstin Wolk

series ordinal

2

1 reference

24 September 2017

language of work or name

1 reference

15 December 2015

1 reference

24 September 2017

1 reference

24 September 2017

5

1 reference

24 September 2017

68

1 reference

https://scigraph.springernature.com/pub.10.1186/s13578-015-0060-8

24 September 2017

0 references

cites work

Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678716

T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678716

Therapeutic opportunities of the IL-22-IL-22R1 system

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678716

Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678716

Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678716

IL-22 increases the innate immunity of tissues

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678716

Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678716

A High Frequency of Peripheral Blood IL-22(+) CD4(+) T Cells in Patients With New Onset Type 2 Diabetes Mellitus.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678716

Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678716

Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26674616

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S13578-015-0060-8

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference

24 September 2017

1 reference